These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15191515)

  • 21. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to: Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Gitlin N; Weaver AL
    Int J Clin Pract; 2006 May; 60(5):609-10; author reply 610-11. PubMed ID: 16700865
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
    [No Abstract]   [Full Text] [Related]  

  • 24. [Insights and views about cardiovascular safety of COX2 inhibitors].
    Wallentin L
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):666, 668, 671. PubMed ID: 15804041
    [No Abstract]   [Full Text] [Related]  

  • 25. [We must learn how to be better to evaluate drug benefits and risks].
    Dahl E
    Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):2003-4. PubMed ID: 16044759
    [No Abstract]   [Full Text] [Related]  

  • 26. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L
    Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vioxx doctors wooed by Merck are now its foes.
    Tesoriero HW
    Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
    [No Abstract]   [Full Text] [Related]  

  • 29. [Five turbulent years of coxibers. Where did the principle of caution go?].
    Håkansson J; Rosenberg P
    Lakartidningen; 2005 May 2-15; 102(18-19):1432-4. PubMed ID: 15929426
    [No Abstract]   [Full Text] [Related]  

  • 30. NSAIDs, including coxibs, probably do more harm than good, and paracetamol is ineffective for hip OA.
    Bjordal JM; Ljunggren AE; Klovning A; Slørdal L
    Ann Rheum Dis; 2005 Apr; 64(4):655-6; author reply 656. PubMed ID: 15769931
    [No Abstract]   [Full Text] [Related]  

  • 31. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.
    Hunt RH
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():10-9. PubMed ID: 16303032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Was Vioxx really that dangerous?
    Park A
    Time; 2005 Feb; 165(9):52. PubMed ID: 15765852
    [No Abstract]   [Full Text] [Related]  

  • 33. [Coxib debate on thin ice].
    Järhult B
    Lakartidningen; 2005 Mar 7-13; 102(10):788-9; discussion 789-90. PubMed ID: 15839175
    [No Abstract]   [Full Text] [Related]  

  • 34. "To do no harm".
    Binymin KA; Phillips K
    Rheumatology (Oxford); 2007 Feb; 46(2):368-70; author reply 370. PubMed ID: 17116655
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
    Scheiman J
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():7-8, 21-4. PubMed ID: 15755267
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract]   [Full Text] [Related]  

  • 37. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A letter which will not change my prescribing patterns].
    Holmberg K
    Lakartidningen; 2002 Nov; 99(48):4906. PubMed ID: 12523081
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complete and independent scrutiny of coxiber is required].
    Håkansson J
    Lakartidningen; 2002 Nov; 99(48):4904. PubMed ID: 12523079
    [No Abstract]   [Full Text] [Related]  

  • 40. Peptic ulcer disease.
    Louw JA
    Curr Opin Gastroenterol; 2006 Nov; 22(6):607-11. PubMed ID: 17053437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.